News

A 32-Year-Old’s Startup, Inspired By A Health Scare, Sells For $275 Million

A teenage health crisis led Surbhi Sarna to found a company aimed at detecting ovarian cancer early. Today Boston Scientific is purchasing Read more...

Boston Scientific Announces Acquisition Of nVision Medical Corporation

Acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer MARLBOROUGH, Mass., April Read more...

Augmenix, Inc. Announces Aetna’s Positive Coverage Decision for the SpaceOAR® Hydrogel Procedure for Men with Prostate Cancer

BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, Inc. is pleased to announce that Aetna, Inc, the third largest commercial health plan Read more...

Ovarian Cancer Doesn’t Begin in the Ovaries, Researchers Say

Ovarian cancer begins with lesions in the fallopian tubes, which if treated early could prevent the cancer from spreading, researchers say A growing body Read more...

Key Strategies for Implementing Proteomics-Based Tests Across Disease States

Xpresys® Lung and PreTRM® Tests Featured as Demonstrating Pathway to Successful Development and Clinical Implementation SEATTLE and SALT LAKE CITY, Read more...

Bill Gates Tells Healthcare’s Capitalists How To Save Five Million Kids

Bill Gates is about to address thousands of top executives, bankers and investors at the year's biggest healthcare industry gathering. His Read more...

Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018

First and only prostate cancer spacing device available for use in the U.S. clinically proven to preserve patient quality of life following radiation therapy BEDFORD, Read more...

Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy Of Spaceoar Hydrogel In Patients Undergoing Dose-Escalated Stereotactic Body Radiation Therapy For Prostate Cancer

Application of SpaceOAR hydrogel significantly reduces rectal injury in a high-dose SBRT treated patient population BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, Read more...

Page 1 of 29123...Last »

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184